The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers

Acute lymphoblastic leukemia (ALL) and Chronic lymphocytic leukemia (CLL) are the most common leukemias in children and elderly people, respectively. Standard therapies, such as chemotherapy, are only effective in 40% of ALL adult patients with a five-year survival rate and therefore new alternative...

Full description

Bibliographic Details
Main Authors: Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan, Cristina Eguizabal
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
CAR-NK
CAR-T
hematological cancer
immunotherapy
blood
Online Access:https://www.mdpi.com/2072-6694/13/21/5418

Similar Items

Similar Items